ML346 NEW

Price	$34	$48	$77
Package	1mg	2mg	5mg

Min. Order:
Supply Ability:	10g
Update Time:	2024-11-14

Product Details

Product Name: ML346	CAS No.: 100872-83-1
Purity: 99.29%	Supply Ability: 10g
Release date: 2024/11/14

Product Introduction

Bioactivity

名稱	ML346
描述	ML346 is a novel activator of Hsp70.
激酶實(shí)驗(yàn)	Assays (25.5 μL volume) are carried out robotically at room temperature (21°C) and are linear with respect to time and enzyme concentration under the conditions used. Assays are performed for 30 min using Multidrop Micro reagent dispensers in a 96-well format. The concentration of magnesium acetate in the assays is 10 mM and [γ-33P]ATP (800 c.p.m./pmol) is used at 5, 20 or 50 μM as indicated, in order to be at or below the Kmfor ATP for each enzyme.The assays are initiated with MgATP, stopped by the addition of 5 μL of 0.5 M orthophosphoric acid and spotted on to P81 filter plates using a unifilter harvester. The IC50 values of inhibitors are determined after carrying out assays at ten different concentrations of each compound[2].
體外活性	ML346 has good chemical stability, significantly high water solubility, is not reactive with excess glutathione, and is cell permeable. The probe ML346 will help elucidate roles for activation of Hsp70 and HSF-1 in the prevention and progression of cancers, cellular aging, and metabolic and neurodegenerative disorders. ML346 is a novel modulator of proteostasis for protein conformational diseases.
體內(nèi)活性	ML346 activates transcription of the Hsp70 promoter and suppresses aggregation of poly-glutamines in a C. elegans model, suggesting the probe has efficacy in modifying protein aggregation and associated toxicity. ML346 induces HSF-1-dependent chaperone expression and restores protein folding in conformational disease models.
存儲(chǔ)條件	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
溶解度	DMSO : 11 mg/mL (40.4 mM), Sonication is recommended.
關(guān)鍵字	response \| inhibit \| probe \| protein \| Heat shock proteins \| Inhibitor \| HSP \| ML-346 \| shock \| conformational \| cytotoxicity \| ML 346 \| heat \| chaperones \| ML346
相關(guān)產(chǎn)品	Ethoxyquin \| SNX0723 \| Tamoxifen \| DN401 \| SNX2112 \| Ganetespib \| Teprenone \| Elesclomol \| Rifabutin \| Palmitic acid \| Paeoniflorin \| Tamoxifen Citrate
相關(guān)庫(kù)	銅死亡化合物庫(kù) \| 表型篩選靶點(diǎn)鑒定庫(kù) \| 經(jīng)典已知活性庫(kù) \| 內(nèi)質(zhì)網(wǎng)應(yīng)激化合物庫(kù) \| 抗乳腺癌化合物庫(kù) \| 代謝化合物庫(kù) \| 已知活性化合物庫(kù) \| 共價(jià)抑制劑庫(kù) \| 細(xì)胞骨架化合物庫(kù) \| 抗代謝疾病化合物庫(kù)

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.